Durable Anti-SARS-CoV-2 Antibody Response after mRNA-1273 Booster in Peritoneal Dialysis Patients during the Omicron Wave

Anti-SARS-CoV-2 vaccination of dialysis patients has been proven to be safe and effective to reduce COVID-19-related morbidity and mortality. However, data on the durability of anti-SARS-CoV-2 antibodies post-vaccination in peritoneal dialysis (PD) patients are scarce. In this prospective single-cen...

Descripción completa

Detalles Bibliográficos
Autores principales: Beilhack, Georg, Monteforte, Rossella, Frommlet, Florian, Reindl-Schwaighofer, Roman, Strassl, Robert, Vychytil, Andreas
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10302227/
https://www.ncbi.nlm.nih.gov/pubmed/37376510
http://dx.doi.org/10.3390/vaccines11061121

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10302227/
https://www.ncbi.nlm.nih.gov/pubmed/37376510
http://dx.doi.org/10.3390/vaccines11061121

Ejemplares similares